Literature DB >> 15383322

Role of the metabotropic P2Y(4) receptor during hypoglycemia: cross talk with the ionotropic NMDAR1 receptor.

Fabio Cavaliere1, Susanna Amadio, Daniela F Angelini, Giuseppe Sancesario, Giorgio Bernardi, Cinzia Volonté.   

Abstract

It is well established that both extracellular ATP and glutamate exert a critical role during metabolic impairment, that several P2 receptor subunits are directly involved in this action and that a strong relationship exists between glutamatergic and purinergic signals. Therefore, here we studied the molecular behavior of the purinergic metabotropic P2Y(4) and the glutamatergic ionotropic NMDAR1 receptors during hypoglycemic cell death. We find that these proteins are oppositely modulated during glucose starvation (P2Y(4) is induced, whereas NMDAR1 is inhibited) and that both P2 and NMDA antagonists can restore basal protein expression levels. Moreover, double immunofluorescence experiments with confocal laser microscopy reveal co-localization at the membrane level between the P2Y(4) and NMDAR1 receptors, in both homologous (cerebellar granule neurons) and heterologous (Hek-293) cellular systems. This is furthermore confirmed by co-immunoprecipitation experiments. Finally, when we express the P2Y(4) receptor in the heterologous SH-SY5Y neuronal cell line, hypoglycemia then causes severe cell death and simultaneous downregulation of the NMDAR1 protein. In summary, our work establishes a potential molecular interplay between P2Y(4) and NMDAR1 receptors during glucose deprivation and the causative role of the P2Y(4) during cell death.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15383322     DOI: 10.1016/j.yexcr.2004.07.009

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  8 in total

Review 1.  Purinergic modulation of granule cells.

Authors:  Raphaël Courjaret; María Teresa Miras-Portugal; Joachim W Deitmer
Journal:  Cerebellum       Date:  2012-03       Impact factor: 3.847

Review 2.  Interaction of P2 purinergic receptors with cellular macromolecules.

Authors:  Laszlo Köles; Zoltan Gerevich; João Felipe Oliveira; Zoltan Sandor Zadori; Kerstin Wirkner; Peter Illes
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-12-19       Impact factor: 3.000

3.  Regional expression of P2Y(4) receptors in the rat central nervous system.

Authors:  Xianmin Song; Wei Guo; Qiang Yu; Xiaofeng Liu; Zhenghua Xiang; Cheng He; Geoffrey Burnstock
Journal:  Purinergic Signal       Date:  2011-07-19       Impact factor: 3.765

Review 4.  Pathophysiology of astroglial purinergic signalling.

Authors:  Heike Franke; Alexei Verkhratsky; Geoffrey Burnstock; Peter Illes
Journal:  Purinergic Signal       Date:  2012-05-01       Impact factor: 3.765

5.  Effects of acute perinatal asphyxia in the rat hippocampus.

Authors:  Juliana Karl Frizzo; Michele Petter Cardoso; Adriano Martimbianco de Assis; Marcos Luiz Perry; Cinzia Volonté; Marcos Emílio Frizzo
Journal:  Cell Mol Neurobiol       Date:  2010-01-23       Impact factor: 5.046

6.  Selective loss of P2Y2 nucleotide receptor immunoreactivity is associated with Alzheimer's disease neuropathology.

Authors:  Mitchell K P Lai; Michelle G K Tan; Sara Kirvell; Carl Hobbs; Jasinda Lee; Margaret M Esiri; Christopher P Chen; Paul T Francis
Journal:  J Neural Transm (Vienna)       Date:  2008-05-28       Impact factor: 3.575

7.  The P2 receptor antagonist PPADS supports recovery from experimental stroke in vivo.

Authors:  Alexandra B Lämmer; Alexander Beck; Benjamin Grummich; Annette Förschler; Thomas Krügel; Thomas Kahn; Dietmar Schneider; Peter Illes; Heike Franke; Ute Krügel
Journal:  PLoS One       Date:  2011-05-17       Impact factor: 3.240

8.  The P2Y₄ receptor forms homo-oligomeric complexes in several CNS and PNS neuronal cells.

Authors:  Nadia D'Ambrosi; Monia Iafrate; Fabrizio Vacca; Susanna Amadio; Alessandro Tozzi; Nicola B Mercuri; Cinzia Volonté
Journal:  Purinergic Signal       Date:  2006-09-28       Impact factor: 3.765

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.